Medicare spending on Ozempic and similar diabetes drugs soars, study finds, and it could end up costing seniors - CNN

Medicare shelled out $5.7 billion on Ozempic and other similar diabetes drugs in 2022, up from $57 million in 2018, according to a new KFF analysis.
The pricey medications, which include Mounjaro an… [+1828 chars]